Rabies Postexposure Prophylaxis - Connecticut, 1990-1994

Morbidity and Mortality Weekly Report

Volumn 45, Issue 11, 1996, Pages 232-234

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RABIES VACCINE; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; DISEASE TRANSMISSION; DRUG UTILIZATION; ECONOMICS; HEALTH CARE COST; HUMAN; IMMUNOLOGY; RABIES; RABIES VIRUS; RACCOON; UNITED STATES; UTILIZATION REVIEW; VACCINATION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CONNECTICUT; DRUG UTILIZATION; HEALTH CARE COSTS; HUMANS; IMMUNOGLOBULINS; RABIES; RABIES VACCINES; RABIES VIRUS; RACCOONS; VACCINATION;

EID: 0030597651     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. CDC. Human rabies - West Virginia, 1994. MMWR 1995;44:86-7,93.
2. CDC. Human rabies - Washington, 1995. MMWR 1995;44:625-7.
3. Connecticut Department of Public Health. Human rabies case - Connecticut. Connecticut Epidemiologist 1995;15:21-2.
4. CDC. Human rabies - Connecticut, 1995. MMWR 1996;45:207-9.
5. CDC. Rabies prevention - United States, 1991: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(no. RR-3).
6. CDC. Raccoon rabies epizootic - United States, 1993. MMWR 1994;43:269-73.
7. Uhaa IJ, Dato VM, Sorhage FE, et al. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. JAVMA 1992;201:1873-82.
8. Public Health Service. Healthy people 2000: national health promotion and disease prevention objectives. Washington, DC: US Department of Health and Human Services, Public Health Service, 1991:122;DHHS publication no. (PHS)91-50213.